Seven men had their prostate specific antigen (PSA) decrease, and follow-up magnetic-resonance–ultrasound fusion biopsy did not detect residual disease in the ablation zone in five men but did find cancer outside the treatment margin in six men [160]. This evidence concerns the gene KLK3 and cancer.